Dorota Pojda-Wilczek

Prof. Dr. Dorota Pojda-Wilczek

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2017 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
ASAnna Skorczyk-Werner
Anna Skorczyk-Werner
WCWei-Chieh Chiang
Wei-Chieh Chiang
AWAnna Wawrocka
Anna Wawrocka
KWKatarzyna Wołyńska
Katarzyna Wołyńska
MJMałgorzata Jarmuż-Szymczak
Małgorzata Jarmuż-Szymczak
MKMaciej Krawczyński
Maciej Krawczyński
Inherited retinal dystrophies (IRDs) are clinically and genetically highly heterogeneous, making clinical diagnosis difficult. The advances in high-throughput sequencing (ie, panel, exome and genome sequencing) have proven highly effective on defining the molecular basis of these disorders by identifying the underlying variants in the respective gene. Here we report two siblings affected by an IRD phenotype and a novel homozygous c.1691A>G (p.(Asp564Gly)) ATF6 (activating transcription factor 6A) missense substitution identified by whole exome sequencing analysis. The pathogenicity of the variant was confirmed by functional analyses done on patients’ fibroblasts and on recombinant p.(Asp564Gly) protein. The ATF6Asp564Gly/Asp564Gly variant shows impaired production of the ATF6 cleaved transcriptional activator domain in response to endoplasmic reticulum stress. Detailed phenotypic examination revealed extinguished cone responses but also decreased rod responses together with the ability to discriminate some colours suggestive rather for cone-rod dystrophy than achromatopsia.

13 May 2016 in Clinical Hemorheology and Microcirculation
Verified
Journal Article
Closed access
PDF file
WRWojciech Rokicki
Wojciech Rokicki
JZJolanta Zalejska-Fiolka
Jolanta Zalejska-Fiolka
DPDorota Pojda-Wilczek
Dorota Pojda-Wilczek
AKAdam Kabiesz
Adam Kabiesz
WMWojciech Majewski
Wojciech Majewski
BACKGROUND: This study was designed to examine oxidative and antioxidative changes in the red blood cells (RBCs) of patients presenting with glaucomatous degeneration. METHODS: The experimental design was a case-control study of strictly selected pat

15 February 2017 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
WRWojciech Rokicki
Wojciech Rokicki
JZJolanta Zalejska-Fiolka
Jolanta Zalejska-Fiolka
DPDorota Pojda-Wilczek
Dorota Pojda-Wilczek
AHAlicja Hampel
Alicja Hampel
WMWojciech Majewski
Wojciech Majewski
EMEwa Mrukwa-Kominek
Ewa Mrukwa-Kominek
Oxidative stress contributes to both intraocular pressure regulation and glaucomatous neuropathy. The systemic redox status (solitary determination) was examined in primary open-angle glaucoma (POAG) patients with cataract and nonglaucomatous cataract patients. Cataract-matched group comparisons appear more precise in the context of oxidative stress evaluation. The aim of this study was to establish if systemic oxidative status in POAG patients was elevated compared with the cataract only subjects. The study included patients with primary open angle glaucoma (POAG group, n = 30) and controls (non POAG group, n = 25). Serum concentration of lipofuscine (LPS), malondialdehyde (MDA) and activity of total superoxide dismutase (SOD), and its mitochondrial (Mn-SOD) and cystolic (Cu,Zn-SOD) isoform were measured. Total oxidant state (TOS) and total antioxidant capacity (TAC) in blood were also evaluated. Significant increase of LPS (p = 0.0002) and MDA (p = 0.005) concentration was observed in glaucomatous patients as compared with controls. Total SOD activity was significantly lowered in the glaucoma group (p = 0.003); serum level of Mn-SOD was significantly lower in glaucoma patients (p = 0.048) however, Cu,Zn-SOD was not. Glaucoma patients presented elevated mean TOS (p = 0.016). Both groups presented with comparable TAC. Systemic redox balance of cataract patients was significantly altered in the course of glaucoma.

16 May 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
IJIrmina Jastrzębska-Miazga
Irmina Jastrzębska-Miazga
BMBartosz Machna
Bartosz Machna
DPDorota Pojda-Wilczek
Dorota Pojda-Wilczek
ASAdrian Smedowski
Adrian Smedowski
The cornea, a highly innervated and avascular ocular tissue, relies on intricate neuro-immune interactions to maintain homeostasis. Among key neuromediators, substance P (SP)—a neuropeptide belonging to the tachykinin family—plays a dual role in corneal physiology and pathology. This review synthesizes current knowledge on SP’s involvement in corneal innervation, epithelial homeostasis, immune regulation, neovascularization, and wound healing, while highlighting its dichotomous effects in both promoting tissue repair and exacerbating inflammation. SP, primarily signaling through the neurokinin-1 receptor (NK1R), influences corneal epithelial proliferation, barrier function, and wound healing by modulating cytokines, chemokines, and growth factors. However, its overexpression is linked to pain sensitization, inflammatory keratitis, and corneal neovascularization, driven by interactions with immune cells (e.g., mast cells, neutrophils) and pro-angiogenic factors (e.g., VEGF). Clinical studies demonstrate altered SP levels in dry eye disease, neurotrophic keratitis, and post-refractive surgery, correlating with nerve damage and ocular surface dysfunction. Emerging therapies targeting SP pathways- such as NK1R antagonists (e.g., fosaprepitant) and SP-IGF-1 combinations-show promise for treating neurotrophic ulcers but face challenges due to SP’s context-dependent actions. Future research should clarify the roles of NK2R/NK3R receptors and optimize SP-based interventions to balance its reparative and inflammatory effects. Understanding SP’s multifaceted mechanisms could advance the development of therapies for corneal diseases, particularly those involving sensory neuropathy and immune dysregulation.

1 March 2009 in Pharmacological Reports
Verified
Journal Article
Closed access
PNPrzemysław Nowak
Przemysław Nowak
DNDariusz Nitka
Dariusz Nitka
AKAdam Kwieciński
Adam Kwieciński
JJJadwiga Jośko
Jadwiga Jośko
JDJacek Drab
Jacek Drab
RBRyszard Brus
Ryszard Brus

Verified
Journal Article
Open access
PDF file
JMJoanna Musialik
Joanna Musialik
ABAnna Maria Maria Boguszewska-Chachulska
Anna Maria Maria Boguszewska-Chachulska
DPDorota Pojda-Wilczek
Dorota Pojda-Wilczek
AGAgnieszka Gorzkowska
Agnieszka Gorzkowska
RSRobert Szymańczak
Robert Szymańczak
AWAndrzej Więcek
Andrzej Więcek
Clinical phenotypes of familial hypobetalipoproteinemia (FHBL) are related to a number of defective apolipoprotein B (APOB) alleles. Fatty liver disease is a typical manifestation, but serious neurological symptoms can appear. In this study, genetic analysis of the APOB gene and ophthalmological diagnostics were performed for family members with FHBL. Five relatives with FHBL, including a proband who developed neurological disorders, were examined. A sequencing analysis of the whole coding region of the APOB gene, including flanking intronic regions, was performed using the next-generation sequencing (NGS) method. Electrophysiological ophthalmological examinations were also done. In the proband and his affected relatives, NGS identified the presence of the pathogenic, rare heterozygous splicing variant c.3696+1G>T. Two known heterozygous missense variants—c.2188G>A, p.(Val730Ile) and c.8353A>C, p.(Asn2785His)—in the APOB gene were also detected. In all patients, many ophthalmologic abnormalities in electrophysiological tests were also found. The identified splicing variant c.3696+1G>T can be associated with observed autosomal, dominant FHBL with coexisting neurological symptoms, and both identified missense variants could be excluded as the main cause of observed clinical signs, according to mutation databases and the literature. Electroretinography examination is a sensitive method for the detection of early neuropathy and should therefore be recommended for the care of patients with FHBL.